Literature DB >> 2574319

Potential protection by cyclosporin against glucocorticoid effects on bone.

P J Kelly, P N Sambrook, J A Eisman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2574319     DOI： 10.1016/s0140-6736(89)91988-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol. The Liver Transplant Group, Groningen.

Authors:  S C Riemens; A Oostdijk; J J van Doormaal; C J Thijn; G Drent; D A Piers; E W Groen; L Meerman; M J Slooff; E B Haagsma
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

2.  Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate.

Authors:  E Meys; F Terreaux-Duvert; T Beaume-Six; G Dureau; P J Meunier
Journal:  Osteoporos Int       Date:  1993-12       Impact factor: 4.507

3.  Mechanisms of rapid bone loss following cardiac transplantation.

Authors:  P N Sambrook; P J Kelly; D Fontana; T Nguyen; A Keogh; P Macdonald; P Spratt; J Freund; J A Eisman
Journal:  Osteoporos Int       Date:  1994-09       Impact factor: 4.507

Review 4.  Drug-induced disorders of bone metabolism. Incidence, management and avoidance.

Authors:  G Jones; P N Sambrook
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

5.  Calcitonin and bisphosphonates treatment in bone loss after liver transplantation.

Authors:  M A Valero; C Loinaz; L Larrodera; M Leon; E Moreno; F Hawkins
Journal:  Calcif Tissue Int       Date:  1995-07       Impact factor: 4.333

6.  Parathyroid function in cardiac transplant patients: evaluation during physical exercise.

Authors:  G Brandenberger; B Schnedecker; K Spiegel; B Mettauer; B Geny; J Sacrez; E Lampert; J Lonsdorfer
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.